83 FR 28663 - Importer of Controlled Substances Application: Fisher Clinical Services, Inc.

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 83, Issue 119 (June 20, 2018)

Page Range		28663-28663
FR Document		2018-13224

Federal Register, Volume 83 Issue 119 (Wednesday, June 20, 2018)

[Federal Register Volume 83, Number 119 (Wednesday, June 20, 2018)]
[Notices]
[Page 28663]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-13224]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: Fisher Clinical 
Services, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before July 20, 2018. Such 
persons may also file a written request for a hearing on the 
application on or before July 20, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.34(a), this is notice that on March 
16, 2018, Fisher Clinical Services, Inc., 7554 Schantz Road, Allentown, 
Pennsylvania 18106 applied to be registered as an importer of 1-[1-(2-
Thienyl)cyclohexyl]pyrrolidine (7473), a basic class of controlled 
substance listed in schedule I.
    The company plans to import the controlled substance in finished 
dosage form for testing and clinical trials purposes only.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under to 21 U.S.C. 952(a)(2). Authorization will not extend to the 
import of FDA approved or non-approved finished dosage forms for 
commercial sale.

    Dated: June 12, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-13224 Filed 6-19-18; 8:45 am]
BILLING CODE 4410-09-P

Federal Register / Vol. 83, No. 119 / Wednesday, June 20, 2018 / Notices 28663

may also be obtained by accessing its Register Representative/DRW, 8701 The company plans to import the
website (http://www.usitc.gov). Persons Morrissette Drive, Springfield, Virginia controlled substance in finished dosage
with mobility impairments who will 22152. All requests for hearing must be form for testing and clinical trials
need special assistance in gaining access sent to: Drug Enforcement purposes only.
to the Commission should contact the Administration, Attn: Administrator, Approval of permit applications will
Office of the Secretary at 202–205–2000. 8701 Morrissette Drive, Springfield, occur only when the registrant’s
Background: All dates and other Virginia 22152. All requests for hearing business activity is consistent with what
information relating to this investigation should also be sent to: (1) Drug is authorized under to 21 U.S.C.
remain the same as in the Commission’s Enforcement Administration, Attn: 952(a)(2). Authorization will not extend
notice of investigation and public Hearing Clerk/LJ, 8701 Morrissette to the import of FDA approved or non-
hearing issued on May 23, 2018 and Drive, Springfield, Virginia 22152; and approved finished dosage forms for
published in the Federal Register of (2) Drug Enforcement Administration, commercial sale.
May 25, 2018 (83 FR 24342). Attn: DEA Federal Register Dated: June 12, 2018.
By order of the Commission. Representative/DRW, 8701 Morrissette John J. Martin,
Issued: June 14, 2018. Drive, Springfield, Virginia 22152.
Assistant Administrator.
Lisa Barton, SUPPLEMENTARY INFORMATION: The
[FR Doc. 2018–13224 Filed 6–19–18; 8:45 am]
Secretary to the Commission. Attorney General has delegated his
BILLING CODE 4410–09–P
[FR Doc. 2018–13176 Filed 6–19–18; 8:45 am] authority under the Controlled
BILLING CODE 7020–02–P Substances Act to the Administrator of
the Drug Enforcement Administration DEPARTMENT OF JUSTICE
(DEA), 28 CFR 0.100(b). Authority to
DEPARTMENT OF JUSTICE exercise all necessary functions with Drug Enforcement Administration
respect to the promulgation and
Drug Enforcement Administration implementation of 21 CFR part 1301, [Docket No. DEA–392]
incident to the registration of
[Docket No. DEA–392]
manufacturers, distributors, dispensers, Bulk Manufacturer of Controlled
Importer of Controlled Substances importers, and exporters of controlled Substances Registration
Application: Fisher Clinical Services, substances (other than final orders in
Inc. connection with suspension, denial, or ACTION: Notice of registration.
revocation of registration) has been
ACTION: Notice of application. redelegated to the Assistant SUMMARY: Registrants listed below have
Administrator of the DEA Diversion applied for and been granted
DATES: Registered bulk manufacturers of Control Division (‘‘Assistant registration by the Drug Enforcement
the affected basic classes, and Administrator’’) pursuant to section 7 of Administration (DEA) as bulk
applicants therefore, may file written 28 CFR part 0, appendix to subpart R. manufacturers of various classes of
comments on or objections to the In accordance with 21 CFR schedule I and II controlled substances.
issuance of the proposed registration on 1301.34(a), this is notice that on March SUPPLEMENTARY INFORMATION: The
or before July 20, 2018. Such persons 16, 2018, Fisher Clinical Services, Inc., companies listed below applied to be
may also file a written request for a 7554 Schantz Road, Allentown, registered as bulk manufacturers of
hearing on the application on or before Pennsylvania 18106 applied to be various basic classes of controlled
July 20, 2018. registered as an importer of 1-[1-(2- substances. Information on previously
ADDRESSES: Written comments should Thienyl)cyclohexyl]pyrrolidine (7473), published notices is listed in the table
be sent to: Drug Enforcement a basic class of controlled substance below. No comments or objections were
Administration, Attention: DEA Federal listed in schedule I. submitted for these notices.

Company FR Docket Published

AMRI Rensselaer, Inc .................................................................................................................................... 83 FR 5808 February 9, 2018.
Stepan Company ........................................................................................................................................... 83 FR 9029 March 2, 2018.
Research Triangle Institute ............................................................................................................................ 83 FR 10523 March 9, 2018.
Rhodes Technologies .................................................................................................................................... 83 FR 12407 March 21, 2018.
Synthcon, LLC ............................................................................................................................................... 83 FR 13141 March 27, 2018.
National Center for Natural Products—Research NIDA MPROJECT .......................................................... 83 FR 13522 March 29, 2018.
Insys Manufacturing LLC ............................................................................................................................... 83 FR 13522 March 29, 2018.
Navinta LLC ................................................................................................................................................... 83 FR 13521 March 29, 2018.

The DEA has considered the factors in against diversion by inspecting and Dated: June 12, 2018.
21 U.S.C. 823(a) and determined that testing each company’s physical John J. Martin,
the registration of these registrants to security systems, verifying each Assistant Administrator.
manufacture the applicable basic classes company’s compliance with state and [FR Doc. 2018–13223 Filed 6–19–18; 8:45 am]
sradovich on DSK3GMQ082PROD with NOTICES

of controlled substances is consistent local laws, and reviewing each BILLING CODE 4410–09–P
with the public interest and with United company’s background and history.
States obligations under international Therefore, pursuant to 21 U.S.C.
treaties, conventions, or protocols in 823(a), and in accordance with 21 CFR
effect on May 1, 1971. The DEA 1301.33, the DEA has granted a
investigated each of the company’s registration as a bulk manufacturer to
maintenance of effective controls the above listed companies.

VerDate Sep<11>2014 17:58 Jun 19, 2018 Jkt 244001 PO 00000 Frm 00057 Fmt 4703 Sfmt 9990 E:\FR\FM\20JNN1.SGM 20JNN1

Document Created: 2018-06-20 00:20:24
Document Modified: 2018-06-20 00:20:24

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of application.
Dates		Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before July 20, 2018. Such persons may also file a written request for a hearing on the application on or before July 20, 2018.
FR Citation		83 FR 28663

83 FR 28663 - Importer of Controlled Substances Application: Fisher Clinical Services, Inc.

DEPARTMENT OF JUSTICEDrug Enforcement Administration

Federal Register Volume 83, Issue 119 (June 20, 2018)

DEPARTMENT OF JUSTICE
Drug Enforcement Administration